The Creation of Chemical Microbiology: The Discoveries ofLouis Pasteur and His School The field of chemical microbiology was created by Pasteur, one of the greatest scientific geniuses of all time. From the history of Pasteur's discoveries, which followed each other in rapid succession through a combination of his very great strength of logical deduction and exceptional power of observation, many important lessons can be drawn.
The starting point of Pasteur's work was when he was asked while Professor of Chemistry in Lille, by the local wine producers, to give them advice as to how to avoid certain irregularities and aberrations in the wine fermentation process which they encountered from time to time without a rational explanation, and which caused them a great deal of trouble and financial losses.
The wine fermentation process at that time was considered to be a purely chemical process resembling the process of autolysis which, in order to obtain the best results, had to be conducted along certain empirical rules handed down over centuries from generation to generation.
Pasteur discovered that the fermentation process was not purely chemical in nature, but was caused by the metabolic activities of living microorganisms: the regular fermentations were brought about by certain types ofyeast, the irregular 'pathological' ones by other yeasts or bacteria.
Once the cause of the 'diseases' of wine and, later, beer had been traced to the action of micro-organisms, it was but a small step to the discovery that many infectious diseases of animals and man were also caused by the action of micro-organisms.
The long chain of the great discoveries of Pasteur and his school, both conceptional and practical, which were extended by the fundamental discoveries of the eminent soil microbiologists at the end of the last century, led thus to the revolutionary results in medicine, surgery, public health and agriculture with which we are all familiar.
Pasteur and his school were thus the first to show that different species of microbes were endowed with specific biochemical activities, such as the production of lower and higher alcohols, lower and higher fatty acids (acetic, propionic, and butyric acid) hydroxy acids (lactic and malic), and toxins responsible for the pathogenic action of bacteria in animals and man. Pasteur and his collaborator Joubert also discovered, as early as 1867, the antagonistic action of microbes against each other, and, moreover, suggested that this phenomenon could be used for therapeutic purposes. They are, therefore, the direct forerunners of the antibiotics development.
Another most important discovery of Pasteur and his school was the discovery of the 'vie sans oxygene', i.e. that certain micro-organisms can grow and exert all their metabolic functions in the absence of oxygen, in fact that for such organisms oxygen is toxic and prevents them from developing, at that time a sensational discovery with many important implications for biochemical and medical research.
The discoveries of the Pasteur era represent even now an almost inexhaustible reservoir for biochemical research projects, and looking back at them through the distance of time, dispassionately and even with the most critical attitude, one is made aware of the fact how few really new ideas have appeared since then.
The Discovery of Alcoholic Fermentation in Cell-free Yeast Extracts by Buchner As far as the subject of this Lecture is concerned, the next important step was taken when Buchner in 1897 found that when compressed yeast was mixed with sand, ground in a mortar and then subjected to the action of a press, a cell-free extract was obtained which was still capable of fermenting sugar to alcohol and CO2.
This discovery made it possible to study the individual components of the enzyme system bringing about the complex process of fermentation; the enzyme system was given by Buchner the collective name zymase. Buchner's success with yeast stimulated work of a similar kind with other metabolic systems, and the next success was the preparation of an enzymic system from muscle performing all the sequence of the reactions of glycolysis, from glycogen to lactic acid. The Discovery of Cozymase by Harden and Young The view that Buchner's yeast extract was just a mixture of high-molecular enzymes was proved erroneous when it was shown by Harden and Young in 1905 that the yeast extract lost its fermenting power on dialysis, but regained it when a concentrate of the dialysate or a small amount of boiled yeast extract, in which all the enzymes were destroyed, was added. It was thus clear that, in addition to high molecular enzymes, the yeast extract contained a factor of low molecular weight which was essential for the functioning of the enzyme system. This factor was given the name of cozymase. It was soon found that cozymase played an essential function not only in yeast metabolism, but also in the metabolism of animal tissues. It was demonstrated that the glycolytic extract prepared from muscle behaved like yeast extracts, needing the presence of cozyrmase for its glycolytic activity. The demonstration that a micro-organism and an animal tissue needed the same substance for their metabolic activity showed for the first time the close similarity of the basic metabolic processes in all living matter.
The isolation and purification of the fermentation cofactor, with which the name of von Euler is prominently associated, and the elucidation of the chemical structure took over twenty years. It necessitated the working up of many hundreds of kilograms of yeast and constitutes the first example of what has become and still is one of the main pillars of biochemical research, the recognition and study of trace factors forming essential components of metabolic systems.
The Discovery of the Biochemical and Biological Function of Coenzymes: Their Identity with Vitamins The extraordinary importance of the yeast cofactor became clear only gradually, over the course of many years, through two lines of investigations which at first seemed unconnected, but eventually converged on each other. One of these was the study of the mechanism of biological oxidation. As biological oxidation is the source of energy for all living matter, it is a subject which has rightly formed the centre of attention of biochemists ever since the beginning of systematic biochemical research.
The study of the components of the fermenting and glycolytic systems showed that the terminal steps of the two processes, i.e. the reduction of acetaldehyde to alcohol and pyruvic to lactic acid, were brought about by two dehydrogenases both of which needed cozymase for their activity.
The elucidation of the chemical structure of cozymase (Fig 1) showed that it was a dinucleotide, containing adenylic acid as one of its constituents. The rest of the molecule was recog-nized by Otto Warburg as a second nucleotidecontaining nicotinamide as base. Warburg, one of the great pioneers in the field of biological oxidation, had put forward the theory, based on a great deal of superb experimental evidence, that biological oxidation was metal catalysed and that iron-containing porphyrins were of special importance in many animal tissues and microorganisms. He postulated that oxygen was activated by these iron porphyrins and made to react with the hydrogen of the substrate to be oxidized; in these reactions with oxygen on the one side and substrate on the other the iron underwent continuous valency changes from the dito trivalent state. Warburg's theory was hotly contested by those who thought that activation of hydrogen was the first and most important step in biological oxidation. Warburg reconciled both these views by recognizing that the nicotinamide moiety of cozymase was a redox system capable of accepting electrons and protons from the substrate and transferring them, through a series of'other redox systems, to the iron-containing. porphyrins and finally to oxygen.
Cozymase, or nicotinamide adenine dinucleotide, as it is now called, was thus shown to bethe first step in a series of oxido-reductions,. known now as the respiratory chain. The second step in this chain is another dinucleotide, termed flavin-adenine dinucleotide (Fig 2) , in which the flavin grouping is reversibly reduced and oxidized. This nucleotide was shown by Warburg and later by others to be the coenzyme of several important -oxidative enzymes. The second line of investigations which led to the understanding of the biological importance of the coenzyme came from biochemical studies of biological nature concerned with nutritional problems.
In the 1890s the Dutch physician Eijkman made -the discovery that fowls fed with polished rice from which the hulls were removed developed a disease with neuropathological symptoms, resembling the disease called beri-beri which was widespread among the natives of Dutch East India who fed on a diet of polished rice. The birds could be cured by feeding them either with unpolished rice or an extract of the hulls.
In 1912 Frederick Gowland Hopkins reported that young rats fed on a calorically adequate diet of carbohydrate, protein and fat would not grow unless their diet was supplemented by 2 ml of milk per day.
There was obviously a factor or factors present in rice hulls and in milk in very small amounts, in the absence of which some important metabolic system in the body did not properly function, just as the enzyme system bringing about the reaction of fermentation or glycolysis did not function in the absence of cozymase.
The factors present in trace amounts in food, the absence of which led to the appearance of characteristic deficiency syndromes, were termed accessory food factors by Hopkins and vitamins by Funk.
The relation between vitamins and enzyme cofactors became clear when a growth factor for animals, discovered in yeast by P Gyorgi and termed vitamin B2, was identified with riboflavin, one of the base moieties of the dinucleotide, flavin-adenine dinucleotide, which has been referred to above as an important member of the respiratory chain, the function of which is to accept electrons and protons from nicotinamide adenine dinucleotide.
The recognition of the function of vitamins as coenzymes was a most important achievement of biochemical research, and has led to results of great theoretical as well as practical importance.
A great deal of research was expended to discover new vitamins. In these studies the ingenuity of the biochemist had to be primarily directed towards finding an appropriate biological test system in which nutritional deficiencies would manifest themselves. Once these conditions were established, the isolation of the factor responsible for the deficiency symptoms was a matter of routine, though often laborious and time consuming and nearly always requiring large amounts of starting material from which eventually a few milligrams of the active principle could be isolated.
The Discovery and Production of Vitamins by Chemical-microbiological Methods
Once the close similarity of the basic metabolic reactions in cells of higher animal tissues and microbial cells had been demonstrated, the possibility suggested itself to use nutritional deficiencies in micro-organisms to discover new growth factors of importance for animal metabolism; micro-organisms grow, ofcourse, much more rapidly than animals and their growth curves can be studied under more readily controllable conditions. Several microbial growth factors were discovered by this technique and shown to have important functions for animal tissues. Among these are pantothenic acid, folic acid, biotin and vitamin B12. The discovery of the latter, the anti-pernicious-anemia factor, and its ready availability marks one of the great advances in therapeutic medicine in which methods of chemical microbiology have played an essential part. It had been known for a long time that there existed a factor in liver which was effective in the treatment of pernicious anemia, but the isolation and study of this factor was impeded by the lack of a suitable test system. The condition of pernicious anwemia could only be studied in man, and after the discovery of the therapeutic effect of liver extracts few clinical cases were available for experimentation. The situation changed overnight when an American bacteriologist, Dr Mary Shorb, working in the Department of Poultry Husbandry of the University of Maryland, discovered that a strain of Lactobacillus lactis Dorner would not grow in a synthetic medium unless supplemented with clarified tomato juice and liver extract.
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Following up the growth factor in liver extracts, she tested a number of commercially available liver extract preparations of different biological potency used for the treatment of pernicious anemia and found that there was an almost linear relationship between their effect on bacterial growth and their potency to effect remission of symptoms in pernicious anemia. Once a quick test for assay of the liver growth factor had become available, it was simple to look for it in sources other than liver, and it was soon found that the same factor was produced by various micro-organisms, including the streptomycin-producing streptomycete S. griseus, various strains of Nocardia and the propionic bacteria, and could be obtained from them in much larger quantities than from liver. It also became possible to develop much more rapid purification methods, with the result that in 1948 the factor was obtained in crystalline form by two groups of industrial workers, Merck and Co in New Jersey, under K Folkers, and the Glaxo Group under E Lester Smith. The crystalline product was a red pigment and contained cobalt, and was found to be fully active in effecting remission in pernicious anmemia. It has a complicated chemical formula (Fig 3) and, unlike most of the other vitamins, cannot be made synthetically, but is produced microbiologically by fermentation methods similar to those used in the production of antibiotics. Fermentation methods are also used for the production of another vitamin, referred to above, riboflavin; it is produced by certain yeast-like organisms such as Ashbya gossypii in amounts so large that it crystallizes in the mycelium and its cost of production competes favourably with that of chemical synthesis.
To summarize this section: Methods of chemical microbiology have led to the recognition of the first coenzyme, the identity of vitamins and coenzymes, the discovery of a number of important new vitamins and production methods for two of these.
Specific Microbiological Oxidation
We now have to discuss another aspect of chemical microbiology of considerable interest for therapeutic medicine, and this is the capability of many micro-organisms to effect specifically directed oxidations.
As has been mentioned above, Pasteur discovered that the principal causative agents of aberrations of beer brewing were the acetic acid bacteria which had the capability of oxidizing alcohol, not completely, as the yeasts do, to CO2 and water, but only partially, to the acetic acid stage. This partial oxidation occurs in two steps, from alcohol to acetaldehyde, and from acetaldehyde to acetic acid:
(1) CH3*CH20H 7* CH3.CHO (2) CH3*CHO -± CH3-COOH In 1898 Gabriel Bertrand, one of the last collaborators of Pasteur, extended the studies of the capabilities of acetobacter strains of bringing about partial oxidations of alcohols, to polyalcohols, and found that certain strains effected the oxidation of only one of the six OH groups in the polyalcohol sorbitol, oxidizing it to L-sorbose. This observation was extended by himself and later workers to other polyalcohols and sugars, and similar types of specific partial oxidation were observed. Thus, for instance, glucose was found to be oxidized to gluconic acid, and gluconic acid to either 5-or 2-ketogluconic acid, according to the strain; butylene glycol to acetoin, glycerin to dihydroxyacetone (Fig 4) . The acetic bacteria effecting these partial oxidations were termed Acetobacter suboxydans. Later, strains of Pseudomonas aeruginosa were found to bring about the same type of reactions.
The first of these reactions, the oxidation of sorbitol to L-sorbose, is of great industrial importance for the synthesis of L-ascorbic acid (vitamin C), as L-sorbose is the starting for the preparation of L-gulonic acid w] be converted to L-ascorbic acid by deh and lactonization ( Fig 5) . Ascorbic acid be synthesized from glucose by a method partial bacterial oxidation is employed steps (Fig 6) . In the first step glucose is ox 5-gluconic acid. This compound, when chemically by catalytic reduction, yields acid, from which L-2 ketagulonic a immediate precursor of ascorbic acid, obtained by bacterial oxidation. The s both bacterial oxidation steps are very h An equally important application of partial hich can microbial oxidation is the oxidation of the steroid Lydration nucleus in specific positions for the synthesis of can also steroid hormones. Many steroid hormones, for in which instance corticosterone, aldosterone and cortii in two sone, have an oxygen function in position 11 of ,idized to the steroid ring system (Fig 7) . It is difficult to reduced introduce this function by the usual oxidation L-idonic techniques of organic chemistry. In fact, in the .cid, the first synthesis of cortisone from the bile acid can be desoxycholic acid 12 steps of the 36 step synthesis, yields in each giving a low yield, were necessary for this igh. operation (Fig 8, see over) . A great advance was made in this field by workers of the Upjohn IOH Company under D H Petersen who discovered o --H that progesterone, a compound much nearer in its i i i . chemical structure to cortisone than desoxycholic acid and readily available from diosgenin, a steroid saponin present in large amounts particularly in Mexican plants of the Liliacec and Dioscoreacee families, could be hydroxylated in position 11 by a mould in a yield of 90 % (Fig 9) . This reduced the number of steps of the cortisone synthesis from 36 to only 11. Later, microorganisms were discovered which were capable of hydroxylating position 21 and 17 of the steroid ring system, and these, used in combination, reduce the synthesis of cortisol from progesterone Inci,in I/ to only four steps (Fig 10) . Cortisone has been superseded active and less salt retaining comp sone, which differs from cortisone bond in 1, 2 position. This dehydro also found to be effected specificall! organism, Corynebacterium simplex addition to strains bringing about 4 tion in 1, 2 position, and oxidation 21 positions, strains were discovere introducing the oxygen function in 15 and 16 position. Many new pharr active steroids have thus become avai the application of methods of che biology.
The Antibiotics
We now come to the discussion o antibiotics, a section of chemical which has become of immense in practical medicine.
It has already been mention phenomenon of microbial antagon described by Pasteur and Joub Following this work many obs microbial antagonisms were record bacteria and bacteria, moulds a moulds and moulds, &c. Nearl;
biologists have occasion to observ of microbial antagonism in their One particularly striking, and example was described in 1929 by bacteriologist, A Fleming, between < genus penicillium, and many imp genic bacteria, mostly Gram-positi Gram-negative cocci. While ti phenomencn of microbial antagon known, very little was known aboul and pharmacological nature of ti responsible for the phenomeno reason in 1938 Florey and I decided I systematic investigation of the ph microbial antagonism with the vie' the active principles, and studying I and pharmacological properties. VW the beginning of this study three oi number of cases of microbial ant cribed in the literature, and tI Fleming's penicillin. This is not th( CH2oH a detailed historical account of the penicillin cO discovery, but I should like to say only that the 0 OH z > reason why penicillin was selected was not because it looked like a promising drug for curing bacterial infections; on the contrary, its chemical properties definitely looked unfavourable with regard to the possibility of its practical applicaprednisone tion in therapeutic medicine. In 1932, i.e. three years after the appearance of Fleming's paper, a rednisone group of chemists in London carried out some chemical work on penicillin, and reported that by the more penicillin was a very unstable compound which ound prednilost its activity under the conditions in which its by a double purification was attempted. genation was The instability of penicillin was the main y by a microreason for my personal interest in the substance, (Fig 11) . In because it was a property by which it differed dehydrogenafrom all other antibacterial agents then known. in 11, 17 and I believed at first that it was some enzyme -d capable of acting on a constituent of the bacterial memthe 7, 11, 14, braneand looking back on this hypothesis from macologically the vantage point of our present knowledge, I was ilable through not so far off the mark, as penicillin is now known mical microto act by inhibiting an enzyme system involved in the synthesis of the bacterial cell wall. Fleming had stated that the penicillin-containing culture medium of this mould was not more toxic than f the field of the ordinary culture medium, and in fact he microbiology injected fairly large amounts of the culture nportance for medium into mice without noticing any ill effects. This apparent non-toxicity of the crude penicillined that the containing culture fluid was, however, no guaranism was first tee, nor even an indication, that the active prinert in 1867. ciple would be a useful chemotherapeutic agent servations of in clinicipractice. Firstly, it was obviously imledbetween possible to predict whether the active principle, and bacteria, after concentration and purification, would still y all microretain the non-toxicity which it showed in the e phenomena greatly diluted state in which it was present in the routine work. culture medium. Secondly, if penicillin had turned now famous, out to be an enzyme as I expected, but which the London fortunately it did not, it would certainly have been a mould of the non-toxic on first injection, but none the less ortant pathouseless from the practical point of view, because, ve, and a few as the inevitable result of its protein nature, it me biological would on continued application have elicited iism was well anaphylactic reactions. From the biochemical t the chemical point of view, however, its study would still have he substances represented a very interesting problem and as )n. For this such well worth pursuing, irrespective of its to undertake a practical application.
Lenomenon of
As I have already said, the first attempts to w of isolating purify penicillin showed that it was not an their chemical enzyme and this made its study even more interle selected for esting. In 1940 we succeeded in isolating a small ut of the large amount of a still very impure preparation of tagonism despenicillin from the culture medium and in hese included demonstrating that this product was a most e occasion for effective chemotherapeutic agent in the treatment of experimental clinical infections in animals. When, later, after a desperate effort made with completely inadequate means, a slightly larger amount of purified penicillin became available in our laboratory, the same striking therapeutic effects were obtained in clinical infections. These experiments, published in 1940 and 1941, heralded in the era of antibiotics as chemotherapeutic agents in bacterial infections. Almost simultaneously, but independently of our own research programme, Waksman and his colleagues began in 1938 a systematic investigation of the antagonistic properties of soil streptomycetes. Waksman, a soil microbiologist, had been interested in this group of micro-organisms for many years, in relation to the problem of humus formation in soil, and over the years had built up a large collection of streptomycetes. In 1944 Waksman and collaborators described the isolation of an antibiotic produced by such microorganisms, which they termed streptomycin. This substance, which was later shown to possess a trisaccharide-like structure (Fig 12) displayed it was demonstrated for the first time that, like the acute infections, tuberculosis was also amenable to chemotherapyan event of primary historic importance.
Following the discovery of the curative properties of penicillin, an intensive search was made mainly in industrial, but also in some academic research laboratories, for micro-organisms displaying antagonistic properties, and this search was even further intensified after the discovery of streptomycin and its chemotherapeutic action in tuberculosis.
As the result of these investigations, several hundred new antibacterial substances were found and a few of these have acquired great clinical importance. Among these is chloramphenicol (Fig 13) (Fig 14) , both broad spectra antibiotics. The former, a nitrobenzene derivative, is active against many Esch. coli and salmonella strains, and has proved to be an effective drug in typhoid infections. The latter have a common polycyclic structure, and are also active against many Gram-negative bacteria, including Ha&mophilus influenza, one of the causative agents of chronic bronchitis; they are widely used for the treatment and prophylaxis of chronic bronchitis and of urinary infections. Both chloramphenicol and the tetracyclines are also active against Grampositive organisms, and are used in infections caused by these organisms where the penicillins for one reason or another cannot be used. Another important group of antibiotics are the polymyxins (Fig 15) . These are polypeptides and the only ones among the antibiotics to display high activity against Pseudomonas pyocyanea; one of them, polymyxin E, has found extensive clinical application, not only for the treatment of Pseudomonas pyocyanea infections, but also for the treatment of urinary Esch. coli infections, which are refractory to other antibiotics. Unfortunately, their nephrotoxicity is a limiting factor in their application.
Several other antibiotics, which can be classified as second-line chemotherapeutic weapons, have found limited clinical use. They comprise the macrolides erythromycin, magnamycin, spira--mycin and others, novobiocin (active against Gram-positive bacteria but rapidly inducing -resistance), cycloserine (active against the tubercle bacillus) and kanamycin, a broad spectrum antibiotic active against the penicillinase-producing staphylococci, the tubercle bacillus and many strains of proteus.
'The Semisynthetic Penicillins An important development in the antibiotics field in recent years is the development of the semisynthetic penicillins. The penicillins are produced by fermentation. They consist of a nucleus termed 6-aminopenivcillanic acid, and a side chain which is a substituted acetic acid.
The most commonly used penicillin contains phenylacetic acid and phenoxyacetic acid as side chain (the latter is acid stable and can therefore be given orally) (Fig 16) . In the biological fermentation process used for the production ofthese penicillins the synthetic side chain acid is added to the culture medium and incorporated by the mould into the nucleus of the penicillin molecule. It was shown by workers of the research staff of a British drug firm, the Beecham Research Laboratories, that in the absence of the side chain precursor acid the penicillin nucleus accumulates in the culture medium. Later, enzymes were discovered in bacteria and streptomycetes which are capable of splitting off the side chain acid from the commercially available penicillins. Thus, the most commonly used and cheapest of the penicillins, benzylpenicillin, can be subjected to hydrolysis by the bacterial enzyme to give a yield of over 80% of the pure crystalline nucleus. The free amino group in the nucleus can be acetylated by a large variety of acids, and thus a correspondingly large number of new penicillins have The situation was similar to that which arose when it was discovered that the active moiety of the azo dye Prontosil was the simple sulphanilamide from which a practically unlimited number of derivatives and analogues can be made. Perhaps the most important outcome of the synthesis of the new penicillins is the discovery of derivatives which are resistant to the action of staphylococcal penicillinase (Fig 17) , and thus are active against the penicillinase-producing strains of staphylococci which rapidly destroy benzylpenicillin and therefore are insensitive to its action. These new penicillinase-resistant penicillins have found widespread use in hospitals and have eliminated the danger of the penicillinresistant staphylococcus. So far no reports of clinical failures with the new penicillins in infections caused by benzylpenicillin-resistant staphylococci have been published. Their introduction must therefore be considered a notable advance in bacterial chemotherapy.
Another interesting new penicillin is ac-aminophenylpenicillin (ampicillin) (Fig 18) . This contains the amino acid side chain phenylglycin and has a broad spectrum of activity, very similar to that of chloramphenicol and the tetracyclines. Moreover it is very effective.against many pathogenic strains of Proteus mirabilis. It has the advantage of a very low toxicity over chloramphenicol and the tetracyclines and has found widespread use in the treatment of chronic bronchitis. It has proved to be very effective in the elimination of Salmonella typhi from typhoid carriers.
The availability of the new penicillins, certainly a useful contribution to therapeutic medicine, is due to a combination of two methods of chemical microbiology: the production of the benzylpenicillin by fermentation, and the enzymatic hydrolysis of its side chain by a bacterial enzyme.
The Production ofLysergic Acid Derivatives The last example of a contribution from chemical microbiology to medicine which I should like to give is one with which my own laboratory has been concerned, the microbiological production of lysergic acid. As you know, there exists a fungal infection of rye and other graminaceous plants, called ergot. The fungus, belonging to the genus claviceps, infects the ovaries of the plant and develops in a special form, called sclerotia. This is a resting form which is more resistant towards adverse environmental conditions than the vegetative hyphal form.
People or cattle eating rye infected with strains of Claviceps purpurea develop severe toxic symptoms, and these were shown to be due to the presence of indole alkaloids containing a characteristic nucleus called lysergic acid and a side chain which is usually of a cyclic tripeptide of a characteristic structure. Some of these ergot alkaloids, such as ergometrine in which the side chain is the simple 2-aminopropanol, have important therapeutic uses in obstetrics, accelerating labour; others such as ergotamine and the synthetic derivative lysergic acid butylamide relieve pain in certain forms of migraine. The ergot alkaloids in clinical use and the lysergic acid used as the starting material for therapeutically important synthetic derivatives were produced from natural ergot collected in artificially infected rye fields, a laborious and time-consuming method, apart from the fact that the ergot yields are sub-ject to big fluctuations depending on weather conditions. For this reason many attempts were made to grow the ergot-producing strains of claviceps in vitro in conditions of submerged culture, the method by which, as mentioned above, the antibiotics and the vitamins B2 and B12 are produced. These attempts failed; the strains were found to grow readily in submerged culture, but only in the vegetative hyphal form, without producing either sclerotia or ergot alkaloids.
Some years ago we decided to take up the problem of ergot alkaloid production with the view of finding the reasons why ergot alkaloids were only produced in vivo, but could not be obtained in culture.
We confirmed at first the negative results obtained by other workers. Then we decided to study the factors responsible for sclerotium formation and began to look for naturally occurring strains of claviceps which would readily give rise to sclerotia formation in vivo. We used to this end a method developed by Lewis at Ann Arbor, which consists in infecting, with a needle, rye embryos with the claviceps strains isolated from various natural sources, and growing the plant from the infected embryo on agar. Of the numerous strains which we tested under these conditions, some would give no infections at all, some would infect the plant but only develop a vegetative mycelium, while yet others would infect the plant and develop sclerotia in various parts of the plant, as happens under natural conditions.
One of the most infective strains and the one which gave rise to abundant sclerotia formation, was a strain of Claviceps paspali isolated from a wild growing paspalum plant on the hills in the neighbourhood of Rome.
The sclerotia formed on the agar-grown plant were transferred to agar, made to germinate and developed mycelium which transformed itself again into sclerotia. The scierotia were transferred to another agar plate, and the vegetative myceli um formed after a few days was used to inoculate shake flasks containing a simple culture medium.
After a few days a mycelium developed wk)im,i, during the later stages of the fermentation, transformed itself into sclerotia-like forms; at the same time the culture fluid began to show the presence of ergot alkaloids by the characteristic colour test. From the appearance of the mycelium on agar it was obvious that it was inhomogeneous, giving rise to white and bluish colonies. In view of the fact that indol derivatives often give rise to dark pigments, the bluish colonies were Eventually strains were obtained which produced up to 1 mg per ml of culture fluid of ergot alkaloids, and now strains are available for industrial production which produce up to 5 mg of alkaloids per ml. This is a yield which approaches that reached in the microbiological production of penicillin by a high yielding strain of Penicillium chrysogenum, and it renders the lysergic acid molecule almost as readily accessible as the penicillin molecule. Isolation and the determination of the chemical structure of the ergot alkaloid formed in submerged culture by the strains of Claviceps paspali showed that it was mainly lysergic acid a-ethoxyamide (Fig 19) , a simple, hitherto unknown derivative of lysergic acid. This derivative can be transformed in high yield into lysergic acid amide, the nucleus of the ergot alkaloids from which many derivatives can be readily made. The situation is similar to that in the above-mentioned field of the semisynthetic penicillins, where the nucleus is produced microbiologically and the side chain made and introduced into the nucleus by chemical methods. Lysergic acid a-ethoxyamide can give rise to new derivatives by reaction of the hydroxy group in the a-ethoxyamide function; it can also be hydrogenated and the hydrogenated product gives rise to similar derivatives. Many new pharmacologically -ictive substances have thus become available and j_ 6iiall hear more about them in the future.
Conclusion
This brief and necessarily superficial survey of a vast area of research has, I hope, demonstrated what I set out to show: that chemical microbiology has made numerous contributions of immense importance to practical therapeutic medicine and there is every reason to believe that it will continue to do so in the future.
